当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 利润表

复星医药

(600196)

  

流通市值:975.72亿  总市值:1243.52亿
流通股本:20.11亿   总股本:25.63亿

利润表

按照会计年度查询:
报告期2021-09-302021-06-302021-03-312020-12-31
一、营业总收入27,048,280,045.3716,952,397,688.868,056,120,184.4330,306,981,264.17
营业收入27,048,280,045.3716,952,397,688.868,056,120,184.4330,306,981,264.17
二、营业总成本25,425,602,296.2315,892,644,096.147,462,843,083.1928,594,718,525.25
营业成本13,382,082,982.518,110,877,794.063,824,213,469.4213,431,177,923
营业税金及附加172,834,094.24115,143,734.0756,145,727.84217,338,579.36
销售费用6,812,675,006.664,356,974,813.892,139,509,791.138,463,943,181.05
管理费用2,250,761,651.931,464,773,983.11673,662,690.772,962,491,697.78
财务费用393,461,038.34282,988,625.23128,473,383.85724,273,093.15
资产减值损失-246,291,983.3-207,333,176.33-7,239,934.59-148,253,541.78
三、其他经营收益-176,803,630.32-132,459,807.9572,425,181.59-589,844,584.54
允许价值变动净收益1,322,786,570.871,182,759,457.5853,698,820.03578,657,017.37
投资净收益1,849,134,316.251,170,797,330.32473,775,582.682,283,980,915.37
联营、合营企业投资收益1,321,105,089.92831,808,948.56258,587,257.461,580,334,829.89
汇兑净收益--------
四、营业利润4,699,216,894.653,327,733,131.131,159,464,118.494,721,145,273.78
营业外收入23,103,255.8820,939,687.043,836,945.5623,084,174.39
营业外支出56,112,339.444,443,360.8118,126,523.6366,385,096.76
非流动资产处置净损失--------
五、利润总额4,666,207,811.133,304,229,457.361,145,174,540.424,677,844,351.41
所得税731,265,667.91550,647,492.17166,517,902.29737,864,579.24
未确认的投资损失--------
六、净利润(百万元)3,564.732,482.37847.193,662.81
少数股东损益370,208,819.69271,209,239.17131,471,039.71277,166,834.19
归属于母公司股东的净利润3,564,733,323.532,482,372,726.02847,185,598.423,662,812,937.98
七、每股收益--0.970.331.43
基本每股收益1.390.970.331.43
稀释每股收益1.390.970.331.43
TOP↑